Inês Pires da Silva
@inespiresilva
Followers
175
Following
305
Media
5
Statuses
121
Joined July 2013
Leading Melanoma Institute Australia (MIA) clinicians and researchers are in Europe to share latest research findings and clinical updates with international colleagues as we continue our efforts to reach zero deaths from melanoma. The 2025 European Society for Medical Oncology
1
1
5
Please join me and other @MelanomaAus multidisciplinary experts at our specialist hybrid #symposium on Neoadjuvant Treatment, so we can ensure the recent PBS listings for #neoadjuvant regimens for Stage III melanoma translate into practice and ultimately better patient outcomes.
0
1
18
@inespiresilva from @MelanomaAus today led an amazing discussion of 4 very different abstract in the #Melanoma & Skin cancer field - presented today #ESMO25 @myESMO very proud!👏🏽 Time to raise the bar (of survivorship & QoL) in #Melanoma
0
1
5
Great day for immunology. The mighty Treg wins 🏅 Congratulations to those involved in the discovery 🎉
BREAKING NEWS The 2025 #NobelPrize in Physiology or Medicine has been awarded to Mary E. Brunkow, Fred Ramsdell and Shimon Sakaguchi “for their discoveries concerning peripheral immune tolerance.”
6
61
516
PhD Opportunity. Join our world-leading team at Melanoma Institute Australia & @Sydney_Uni to investigate why liver metastases reduce response to life-saving #immunotherapy in #melanoma & develop new strategies to overcome it. What you’ll do: • Analyse patient immune profiles &
0
4
14
INNOVATE conference Naples - I love this think tank meeting! 2nd yr colleague Paolo Ascierto has hosted small but lively group of clinician researchers, clinical trialists and drug developers discuss an ALL #CANCER #NEOADJUVANT #immunotherapy approach. It is one of my favourite
0
3
52
Congratulations @JorjaBraden! 👏👏👏
https://t.co/nHu5dlpO0g Features readily identifiable on H&E offer an early on-treatment indicator of response and recurrence to neoadjuvant treatment in melanoma #melanoma #neoadjuvant @MelanomaAus @ProfGLongMIA
0
0
3
https://t.co/hHWeSZshG1 This #science is exciting! It shows the power of vision & action in an inspired team. Within 12 days of 1st dose of triple combination #immunotherapy in #glioblastoma 1) >8x more immune cells in the #GBM, 2) immune cells were newly activated & 3) PD1 drug
nature.com
Nature Medicine - A patient with newly diagnosed glioblastoma was safely treated with neoadjuvant nivolumab, relatlimab and ipilimumab before maximal resection, with comprehensive immune profiling...
5
16
113
Brilliant #AMC2024 session this morning on 'Primary resistance to immunotherapy in melanoma: What's next'? presented by @inespiresilva, @McArthurGrant, @Robbotommo & @omichielin. This session concluded with an insightful panel discussion. #TogetherAmplifyingImpact
0
1
9
Inspiring #AMC2024 discussions: 'Overview of peri-operative systemic therapies'- neodjuvant therapy, histopathology & surgery considerations, personalised vaccines, clinical stage II & III melanoma @amenzies9 @Robbotommo @davidgyorki @inespiresilva #VictoriaAtkinson #RobertRawson
1
3
7
Fantastic #melanoma conference - Society for Melanoma Congress 2024 in USA! @MelanomaAus team presented on #neoadjuvant #immunotherapy, artificial intelligence for pathological response & immune tumour microenvironment. Also on our personalised immunotherapy platform (PIP) &
1
6
61
At #ESMO24, 1 of A/Prof @inespiresilva's 2 posters detailed #NeoRisk predictive tool for neoadjuvant therapy response. Tool takes into account patient’s demographics, disease characteristics + pathological & imaging data. Will help guide treatment. https://t.co/WOOFYRbfvj
@myESMO
0
1
12
NEW content online! Exploiting temporal aspects of cancer immunotherapy https://t.co/ai26Lwen8q
2
139
404
a combined effort from @ProfGLongMIA , @inespiresilva , @ValsamoA and Joost Lesterhuis @telethonkids @telethonkidsCC
@fredhutch @JohnsHopkins @KimmelCancerCtr @MelanomaAus @Sydney_Uni @CPC_usyd
0
1
3
🎉 Congratulations to our medicine and health researchers: Dr Tuba Gide Dr @CameliaQuek Dr @NicholasJHunt1 Dr @ShaniaLiu_ Dr @anagha_killedar Dr @katprior1 Dr @PetrovicFabijan A/Prof Ines Esteves Domingues Pires da Silva Dr @EmmaDevenney1 Prof David Beard Prof Anthony Cunningham
1
1
14
Congratulations @brownjlauren! 👏👏👏🇦🇺
Congratulations to all of these @IASLC Academy participants - early-career physicians interested in academic careers in thoracic oncology, partnered with expert mentors through the year. Looking forward to seeing all that you do!
0
0
3
Well done @brownjlauren and @DrBenKong 👏👏👏
@brownjlauren Well done @brownjlauren for putting this together it was a pleasure to work with @MarlieseAlex @DasanthaJ @DrJoeWei @laurengray4_ @Mal_Itchins @AdnanNagrial @inespiresilva amongst others outside the X-sphere!
1
0
2
Very well deserved! Congratulations to @ProfGLongMIA and @ProfRScolyerMIA! 👏👏👏
Still buzzing after last night’s @ausoftheyear award, alongside my @MelanomaAus colleague and friend @ProfRScolyerMIA . So overwhelmed & humbled by all messages of support, truly appreciated. We share this award with all #melanoma patients, their families, & all #cancer patients
0
0
10
0
3
33
Congratulations @ProfGLongMIA & @ProfRScolyerMIA!!!! 👏👏👏👏
Congrats to @ProfGLongMIA & @ProfRScolyer, tonight jointly named 2024 NSW @ausoftheyear. What an incredible & inspiring group of nominees. Award is testament to Richard & Georgina’s dedication to life-saving cancer research & treatment, for melanoma & now brain cancer. So proud!
1
0
27